Open AccessTelmisartan 40 or 80 mg/hct 12.5 mg fixed dose combinations provide superior bp reductions compared to losartan 50 mg/hct 12.5 mg fixed dose combination during the last 6 hours of the dosing interval: an abpm comparison
Author(s) -
J NEUTEL
Publication year - 2004
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1016/j.amjhyper.2004.03.309
Subject(s) - telmisartan , medicine , losartan , hydrochlorothiazide , urology , clinical endpoint , dosing , angiotensin ii , pharmacology , randomized controlled trial , blood pressure
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom